Pioneer in phage-based diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations
Menu
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations

TB drug research

Tuberculosis (TB) research and innovation is essential to achieve global TB targets for reductions in TB incidence and TB deaths. A quarter of the world‘s population is estimated to have TB infection and are at greater risk of developing TB disease, especially those with weakened immunity.

On average, 5–10% of people who are infected with TB will develop disease over the course of their lives.

Early diagnosis of TB, systematic screening, preventive treatment of persons, and vaccination against TB are some of the key components in the WHO pillars for the End TB strategy.

Actiphage plays a unique role in the detection of mycobacterium tuberculosis (Mtb) to potentially allow rule-in of infected individuals for preventive therapy and rule-out for TB vaccination.

  • Ground-breaking science – clinical studies have shown promise in predicting which individuals with latent tuberculosis might progress to active disease.
  • Companion diagnostic – Actiphage may simplify drug discovery, accelerate clinical study timelines, reduce patient sample size, lower overall costs, and expedite regulatory approval. 
  • Targeted Testing & Treatment – Actiphage distinguishes viable, active mycobacteria, potentially supporting preventive drug treatment or whether the patient is a candidate for vaccination.
  • Personalized Medicine – Actiphage may facilitate prescribing according to strain, health status, and genomics.

TB prevention therapy
Biomarker for TB prevention
Unique role in TB testing
What is Actiphage?
Actiphage clinical studies
Actiphage clinical studies
For Research Use Only
For Research Use Only
Contact us
Contact us

Contact Us

General contact form

Name(Required)
Location

developers of phage-based diagnostics

Contact Us
BIVDA member 2023

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!